Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

2010 01 27 Surveying the ELN Landscape

My talk from SMI ELN conference looking at the ELN landscape:
• Business drivers
- Comparing the different sectors and disciplines
• Build or buy?
• An overview of the solution space
• Patterns of success

  • Be the first to comment

2010 01 27 Surveying the ELN Landscape

  1. 1. Surveying the ELN Landscape Simon Coles CTO & Co-Founder, Amphora Research Systems
  2. 2. My blog: 2
  3. 3. Copies of these slides My blog: 2
  4. 4. About Amphora • Started in ELNs in 1996 • Globally deployed, fully electronic ELN for Kodak • Grew from there... • Now work with large & small companies • Biotechs, Pharma, Chemicals My blog: 3
  5. 5. Some people we work with
  6. 6. Some people we work with
  7. 7. What we do • Patent Evidence Creation & Preservation • Make lawyers happy • Which means you can make scientists happy My blog: 5
  8. 8. What we do • Sometimes our stuff is used... • Standalone • In conjunction with other “ELN” products • With in house systems My blog: 6
  9. 9. Why me? • We do the Patent Evidence problem • You still need to make the scientists happy • So we get a ring-side seat on some of these problems • We cross all the different ELN industries My blog: 7
  10. 10. ELN Landscape • Business drivers - comparing the different sectors and disciplines • Build or buy? • An overview of the solution space • Patterns of success My blog: 8
  11. 11. Why? • Why do we care about the ELN landscape? • Because it helps us all communicate • Perspective on the lessons learned in other areas My blog: 9
  12. 12. The “ELN” Word • Very ambiguous • Probably best if you didn’t use it • Say what you mean My blog: 10
  13. 13. What do you mean? • The term “ELN” means different things to different people • Somewhere the scientists will work • A Patent Evidence system (& long term record) My blog: 11
  14. 14. What is an ELN? Corporate aspects (Records, IP protection, Sharing) Medicinal Chemistry Process Chemistry Molecular Biology Pharmacology Etc. My blog: 12
  15. 15. Patent Evidence • Typically this is a broad, thin layer • Consistently applied across the whole company • Keep it out of the scientific systems • Single, well defined place • Under the control of Custodian My blog: 13
  16. 16. Patent Evidence • Typically this is a broad, thin layer • Consistently applied across the whole company • Keep it out of the scientific systems • Single, well defined place • Under the control of Custodian My blog: 13
  17. 17. Industry/Company Type • Life Sciences • Biotech or Pharma • Biology Vs Chemistry • Diverse Chemicals My blog: 14
  18. 18. Biotech Vs Pharma • Pharma tend to be much more “Mature” organisations • Everything is done in an Enterprise Way • Often have a large amount of established code • Instincts are to buy, but have the resources to build • Biotech can be much lighter on their feet • Simpler problems • Smaller, younger organisations • Instinct is to build for competitive advantage, management often to buy My blog: 15
  19. 19. Differences that make a Difference • There are 2 key aspects which impact the character of your ELN implementation • Regulated Vs Unregulated • Industry My blog: 16
  20. 20. Regulated or not? • If you are regulated, chances you are talking about process automation, enforcement, and compliance • This isn’t easy, but it is • Relatively unambiguous • Fairly well mapped already My blog: 17
  21. 21. ELNs in a Regulated Area • The functions of a “Notebook” will often be done electronically by something else • It won’t be called an “Electronic Lab Notebok” • Mixing regulated none regulated generally makes life unbearably exciting My blog: 18
  22. 22. Chemistry Vs Biology • In Life Sciences, the biggest distinction is between Chemists and Biologists My blog: 19
  23. 23. Chemistry • Chemistry is pretty structured • Buy (or build) them a Chemistry-centric ELN and let them get on with it • The selection process is detailed but at least the work relatively consistently My blog: 20
  24. 24. Sources of Chemistry ELNs • If you’re a big pharma, you’re probably already set • With varying success - this isn’t easy • Solutions • Buy off the shelf • Build from what you have • Vendor capture My blog: 21
  25. 25. Sources of Chemistry • In Biotechs, you probably can’t afford to build or do vendor capture • Unless Cheminformatics is a core strength • So you’re going to have do as much as you can with off-the-shelf (customised as needed) • Nice selection of vendors, have fun! My blog: 22
  26. 26. Biology • Massive diversity • Lots of Microsoft Office and other “non ELN” applications • Best approach is to get out of their way My blog: 23
  27. 27. Biology-specific ELNs • There are some biology-specific ELNs • Rely on the construction of templates for each area • Work well for very structured areas • Hard to deploy over a large area because of diversity • Quickly run into the “You’ve just made Excel harder to use” problem My blog: 24
  28. 28. Examples • Biology in Janssen (IQPC Brussels 2007) • Really good example of in-depth analysis of process • 98% approval rate on a project that size is pretty stunning My blog: 25
  29. 29. Small/Medium Chemicals • Lots of point solutions • Rarely have the money do to anything other than implement an off-the-shelf package in a small area • Relatively simple problem • Significant successes in certain cases My blog: 26
  30. 30. Large Chemicals • Somewhat boring places you may or may not have heard of • But employ 1,000 of scientists and make most of the fun stuff in your house and car • e.g. companies like Kodak, BASF, PPG, Milliken, USG, etc. My blog: 27
  31. 31. Large Chemicals • Massive diversity • R&D is typically very close to the customer • Tight timescales • Low tolerance for “non-value add” activities • Not as much “Chemistry” as you’d think My blog: 28
  32. 32. Large Chemicals • The ELN project will “Open the can of worms” in terms of • The tools people are using • The records they are creating • The patent evidence that is generated My blog: 29
  33. 33. General Purpose ELNs • “You all use the same Paper notebook don’t you?” • “So surely you can all use the same Electronic notebook?” My blog: 30
  34. 34. General Purpose ELNs • You can do it for small numbers of users and certain styles of work • Where workflow is important • For large numbers of users • The diversity in process will kill you • You end up building an expensive version of Word & Excel My blog: 31
  35. 35. General Purpose ELNs Functionality Number of users My blog: 32
  36. 36. General Purpose ELNs Functionality Possible Number of users My blog: 32
  37. 37. General Purpose ELNs Functionality Possible Possible Number of users My blog: 32
  38. 38. General Purpose ELNs Functionality Possible Doomed to fail The organisation will frustrate you Possible Number of users My blog: 32
  39. 39. Front end tools • Most organisations will end up providing different front ends to different users • Examples • BMS, Solvay, J&J, BASF, all the other large companies My blog: 33
  40. 40. Patents • As a rule, what you need to do from a Patent perspective is pretty generic • You might have some specific needs, but 95% of what you need can be done off the shelf • This is one area where you want to stick with best practice and leave it alone My blog: 34
  41. 41. Records Management • The Cinderella of ELN projects • Desperately important • Clearly something that’s dependent on your own processes My blog: 35
  42. 42. Build or Buy? • I don’t believe there’s one true answer here • There’s a resurgence in components to allow a “Build” decision • e.g. Cheminformatics as a service • Decision will be down to • Internal capabilities • Degree of specialisation • Ultimately all project teams will be constructing an “ELN System” from components – whether they are called “ELN”s, or other lower-level parts My blog: 36
  43. 43. Conclusions • Our original question • Some thoughts My blog: 37
  44. 44. Our Questions • What’s the differences that make a difference? • What simple things can you do to increase your chance of success? My blog: 38
  45. 45. Differences • Life Sciences Vs Everyone else • In Life Sciences • Biology Vs Chemistry • Biotech-ish Vs Pharma-ish • Regulated or not? My blog: 39
  46. 46. Beware the ELN word • Say what you mean • Expect different front ends to support different work My blog: 40
  47. 47. Changing the world • Unless you have been specifically charged with changing the workflow • Don’t pick the fight • You’re there to support the science • Today and in the future My blog: 41
  48. 48. Conclusions • They’ve probably already got what they need anyway • Or a very good idea of what they need • That’s why they asked for an ELN in the first place My blog: 42
  49. 49. Conclusion • If you are charged with changing the workflow • That’s your project, not “ELN” or whatever • Try to keep the scope as small as possible • Size and diversity will kill you My blog: 43
  50. 50. Patent Evidence • Stick with best practice unless you really know what you are doing • One single system My blog: 44
  51. 51. Conclusion • Chemistry - buy, or build, the best you can • Biology - get out of their way • Large chemicals - you’ll never fully understand everything in detail My blog: 45
  52. 52. Thank You • Slides will be on our web site tonight • Any questions? My blog: 46